"Effect of Screening Using Imaging (CT/ EUS) on Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) in Patients With New Onset Diabetes (NOD)" - A Prospective Pilot Observational Study

"Effect of Screening Using Imaging (CT/ EUS) on Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) in Patients With New Onset Diabetes (NOD)" - A Prospective Pilot Observational Study

To assess whether EUS (Endoscopic Ultrasound) can serve as a valuable diagnostic tool for identifying PDAC at an early stage in individuals who have recently been diagnosed with diabetes.

Purpose: To improve the rates of early detection of pancreatic cancer.

Pancreatic ductal adenocarcinoma (PDAC) is a type of cancer that starts in the pancreas, a gland located in your abdomen. It happens when some cells in the pancreas start growing abnormally and form a cancer.

Inclusion Criteria:

• Age > 50 years
• Patients diagnosed with diabetes based on FBS/ PPBS/ HbA1C
• Presence of atleast 1 FBS parameter measured in the past 6-18 months which was not > 125 mg/dl
• END-PDAC score > 2

Exclusion Criteria:

• Known or newly detected chronic pancreatitis
• Past history of pancreatic cancer
• History of steroid use
• Contraindications for EUS